WHWK
Whitehawk Therapeutics, Inc.
3.90$
+1.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | |
| 211.2% | 216.5% | 266.1% | 224.5% | 149.8% | 209.1% | 10.6% | – | – | – | – | – | – | |
| -111.2% | -116.5% | -166.1% | -124.5% | -49.8% | -109.1% | 89.4% | – | – | – | – | – | – | |
| 199.5% | 201.8% | 253.9% | 211.9% | 138.6% | 198.2% | 123.0% | – | – | – | – | – | – | |
| 188.3% | 163.5% | 198.4% | 127.7% | 99.6% | 152.7% | 179.4% | – | – | – | – | – | – | |
| 188.3% | 163.5% | 198.4% | 127.7% | 136.2% | 152.7% | 302.4% | – | – | – | – | – | – | |
| -299.5% | -280.0% | -364.5% | -252.2% | -186.0% | -261.8% | -213.0% | – | – | – | – | – | – | |
| 1.0% | 0.9% | 1.1% | 0.9% | 0.5% | 0.0% | 0.0% | – | – | – | – | – | – | |
| -273.6% | -257.2% | -341.7% | -236.0% | -174.0% | -252.4% | 1,021.9% | – | – | – | – | – | – | |
| -273.6% | -257.2% | -341.7% | -236.0% | -174.0% | -252.4% | 1,021.9% | – | – | – | – | – | – | |
| -271.9% | -255.6% | -339.6% | -234.3% | -148.8% | -251.8% | 1,022.6% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.